Evidence map›Paper›PMID 41586772›Full record

ArticleGut microbes2026

Gut bacteria presence in the brain is increased after ischemic stroke in mice.

Alex Peh, Evany Dinakis, Michael Nakai, Rikeish R Muralitharan, Samoda Rupasinghe, Jenny L Wilson, Connie H Y Wong, Hamdi A Jama, Charlotte M O Barker, Mahnaz Modarresi and 4 more

Abstract read
In one paragraph

Article in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alex PehHypertension Research Laboratory, School of Biological Sciences, Monash University, Melbourne, Australia.ORCID 0000-0003-3409-7405
Evany DinakisHypertension Research Laboratory, School of Biological Sciences, Monash University, Melbourne, Australia.
Michael NakaiHypertension Research Laboratory, School of Biological Sciences, Monash University, Melbourne, Australia.
Rikeish R MuralitharanHypertension Research Laboratory, School of Biological Sciences, Monash University, Melbourne, Australia.
Samoda RupasingheCardiovascular & Pulmonary Pharmacology Group, Department of Pharmacology, Monash University, Melbourne, Australia.
Jenny L WilsonCentre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences at Monash Health, Monash Medical Centre, Clayton, Victoria, Australia.
Connie H Y WongCentre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences at Monash Health, Monash Medical Centre, Clayton, Victoria, Australia.
Hamdi A JamaHypertension Research Laboratory, School of Biological Sciences, Monash University, Melbourne, Australia.
Charlotte M O BarkerCardiovascular & Pulmonary Pharmacology Group, Department of Pharmacology, Monash University, Melbourne, Australia.
Mahnaz ModarresiCardiovascular & Pulmonary Pharmacology Group, Department of Pharmacology, Monash University, Melbourne, Australia.
Barbara K Kemp-HarperCardiovascular & Pulmonary Pharmacology Group, Department of Pharmacology, Monash University, Melbourne, Australia.
Tenghao ZhengHypertension Research Laboratory, School of Biological Sciences, Monash University, Melbourne, Australia.
Francine Z MarquesHypertension Research Laboratory, School of Biological Sciences, Monash University, Melbourne, Australia.ORCID 0000-0003-4920-9991
Brad R S BroughtonCardiovascular & Pulmonary Pharmacology Group, Department of Pharmacology, Monash University, Melbourne, Australia.ORCID 0000-0001-8844-974X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic infections are a common cause of complications and death after stroke. These infections can occur due to the breakdown of the gut epithelial barrier and the translocation of bacteria from the gut to peripheral systemic tissues. However, it remains unclear whether gut bacteria also translocate to the brain and contribute to stroke-induced neuronal damage. In this study, we observed a significant number of peptidoglycan- and lipopolysaccharide-positive bacteria in the ischemic hemisphere of mice subjected to either photothrombotic (PT) stroke or middle cerebral artery occlusion (MCAO). In contrast, no bacteria were observed in the ischemic brains of germ-free mice following MCAO. Absolute quantification via PCR also revealed increased bacteria in the ischemic hemisphere and blood of PT mice. Bacterial translocation to the brain is associated with the breakdown of the gut-epithelial and blood-brain barriers. Although inhibition of sympathetic tone reduces gut-epithelial barrier permeability, the bacterial load in the brain and functional deficits poststroke, it does not affect cerebral apoptosis, neuroinflammation or infarct volume. Collectively, these findings indicate that activation of the sympathetic nervous system after stroke promotes the migration of gut-derived bacteria into the ischemic brain, and this process worsens motor function in mice.

Indexed as

BacteriaBrainBrain IschemiaGastrointestinal MicrobiomeIschemic StrokeStrokeAnimalsBacterial TranslocationBlood-Brain BarrierDisease Models, AnimalInfarction, Middle Cerebral ArteryIntestinal Barrier FunctionLipopolysaccharidesMaleMiceMice, Inbred C57BLLipopolysaccharidesPeptidoglycandysbiosisgut microbiomeStrokesympathetic nervous system

Identifiers

PMID41586772
PMCPMC12851396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.